SCINAI IMMUNOTHERAPEUTICS LTD. Net Change in Cash
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Net Change in Cash of -$284.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-04-01
- SCINAI IMMUNOTHERAPEUTICS LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$3.29M.
- SCINAI IMMUNOTHERAPEUTICS LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$1.99M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|
| 2025-12-31 | -$284.00K 20-F · filed 2026-04-01 | ||
| 2025-06-30 | -$964.00K 6-K · filed 2025-09-02 | ||
| 2024-12-31 | -$2.92M 20-F · filed 2026-04-01 | ||
| 2024-06-30 | -$1.92M 6-K · filed 2025-09-02 | ||
| 2023-12-31 | -$9.21M 20-F · filed 2026-04-01 | ||
| 2023-06-30 | -$6.58M 6-K · filed 2024-09-09 | ||
| 2023-03-31 | -$3.29M 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | -$3.30M 20-F · filed 2025-05-07 | ||
| 2022-06-30 | -$6.09M 6-K/A · filed 2023-08-18 | ||
| 2022-03-31 | -$1.99M 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | $14.44M 20-F · filed 2024-05-15 |